1 |
Parameswaran R, Brooks S, Sadler GP (2010). Molecular pathogenesis of follicular cell derived thyroid cancers. Int J Surg, 8, 186-93.
DOI
ScienceOn
|
2 |
Omar E, Madhavan M, Othman NH (2004). Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications. Pathology, 36, 152-9.
DOI
ScienceOn
|
3 |
Morita N, Ikeda Y, Takami H (2008). Clinical significance of p53 protein expression in papillary thyroid carcinoma. World J Surg, 32, 2617-22.
DOI
|
4 |
Nasir A, Catalano E, Calafati S, et al (2004). Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid. in vivo, 18, 189-95.
|
5 |
Park KY, Koh JM, Kim YI, et al (1998). Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population. Clin Endocrinol (Oxf), 49, 317-23.
DOI
|
6 |
Park YK, Park HR, Chi SG, Ushigome S, Unni KK (2001). Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma. Int J Oncol, 19, 353-7.
|
7 |
Park MI, Kang DY (2006). Usefulness of Galectin-3, cytokeratin 19, p53 and Ki-67 for the differential diagnosis of thyroid tumors. Korean J Pathol, 40, 86-92.
|
8 |
Tan A, Etit D, Bayol U, Altinel D, Tan S (2011). Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Ann Diagn Pathol, 15, 108-16.
DOI
ScienceOn
|
9 |
Zafon C, Obiols G, Castellvi J, et al (2007). Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma. Histopathology, 50, 225-31.
DOI
ScienceOn
|
10 |
Hosal SA, Apel RL, Freeman JL, et al (1997). Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biological behavior. Endocr Pathol, 18, 21-8.
|
11 |
Hansen JE, Fischer LK, Chan G, et al (2008). Antibody-mediated p53 protein therapy prevents liver metastasis in vivo. Cancer Res, 67, 1769-74.
|
12 |
Jung TS, Kim K-S, Oh YL, Jung JH (2007). p53, p21 and Bcl-2 protein expression and the clinical significance in papillary thyroid carcinoma. J Korean Endo Soc, 22, 98-104.
DOI
ScienceOn
|
13 |
Horie S, Maeta H, Endo K, et al (2001). Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features. Pathol Int, 51, 11-5.
DOI
ScienceOn
|
14 |
Cvejic D, Selemetjev S, Savin S, et al (2008). Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid. Pathology, 40, 475-80.
DOI
ScienceOn
|
15 |
Gauchotte G, Philippe C, Lacomme S, et al (2011). BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis. Pathology, 43, 447-52.
DOI
|
16 |
Hamzany Y, Soudry E, Strenov Y, et al (2012). Early death from papillary thyroid carcinoma. Am J Otolaryngol, 33, 104-8.
DOI
ScienceOn
|
17 |
Karlidag T, Cobanoglu B, Keles E, et al (2007). Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis. Am J Otolaryngol, 28, 31-6.
DOI
ScienceOn
|
18 |
Liu MC and Gelmann EP (2002). P53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol, 29, 246-57.
DOI
ScienceOn
|
19 |
Kim BS, Kang KH, Lim YA, Kim LS (2009). Clinical significance of p53, Ki-67 and Galectin-3 expressions in papillary thyroid carcinoma. J Korean Surg Soc, 77, 29-36.
과학기술학회마을
DOI
ScienceOn
|
20 |
Dellis RA, Lloyd RV, Heitz U, Eng C (2004). Pathology and Genetics. Tumours of Endocrine organs. Lyon: World Health Organization, IARC Press.
|
21 |
El Demellawy D, Nasr A, Alowami S (2008). Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. Diagn Pathol, 6, 3-5.
|
22 |
Balta AZ, Filiz AI, Kurt Y, et al (2012). Prognostic value of oncoprotein expressions in thyroid papillary carcinoma. Med Oncol, 29, 734-41.
DOI
ScienceOn
|